760179

544709

GAUDIUMIVF

img img img img
No Data Available

Gaudium Ivf N Women H L Share Price Update

GAUDIUM IVF N WOMEN H L made its market debut on 2026-02-27 and is currently trading at ₹112.39, down by ₹-2.29 from its previous close. Today's session has seen the stock move between ₹112.39 and ₹112.39.

Gaudium Ivf N Women H L performance

Today’s low Today’s high
₹ 112.39 ₹ 112.39
₹ 112.39
52 week low 52 week high
₹ 69.18 ₹ 133.00
₹ 112.39
Open Price ₹ 112.39
Prev. Close ₹ 114.68
Volume (Shares) 7530.00
Total traded value ₹ 8.46
Upper Circuit ₹ 116.97
Lower Circuit ₹ 112.39
info

Investment Returns

Over 1 Month -0.83% Over 3 Months 38.63% Over 6 Months 42.88% Over 1 Year 0.00%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

Gaudium Ivf N Women H L fundamentals


  • Market cap (Cr) 818.10
  • P/E Ratio (TTM) 37.29
  • Beta 1.50
  • Book Value / share 20.50
  • Return on equity 51.57%
  • EPS (TTM) 3.06
  • Dividend yield 0.00%
  • Net profit/quarter (Cr) 7.73
info icon alternate text
  • Market cap (Cr) 814.10
  • P/E Ratio (TTM) 37.29
  • Beta 1.32
  • Book Value / share 20.50
  • Return on equity 51.57%
  • EPS (TTM) 3.06
  • Dividend yield 0.00%
  • Net profit/quarter (Cr) 7.73
info icon alternate text

Gaudium Ivf N Women H L Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars MAR 2026 (Values in Cr)
Revenue 22.17
Operating Expense 12.75
Net Profit 7.73
Net Profit Margin (%) 34.86
Earnings Per Share (EPS) 1.24
EBITDA 11.44
Effective Tax Rate (%) 19.39
Particulars DEC 2025 (Values in Cr)
Revenue 14.19
Operating Expense 9.95
Net Profit 3.18
Net Profit Margin (%) 22.41
Earnings Per Share (EPS) 0.52
EBITDA 5.93
Effective Tax Rate (%) 26.66
Particulars SEP 2025 (Values in Cr)
Revenue 22.95
Operating Expense 10.77
Net Profit 9.03
Net Profit Margin (%) 39.34
Earnings Per Share (EPS) 1.47
EBITDA 13.40
Effective Tax Rate (%) 26.66
Particulars JUN 2025 (Values in Cr)
Revenue 12.27
Operating Expense 0.00
Net Profit 2.35
Net Profit Margin (%) 19.15
Earnings Per Share (EPS) 0.32
EBITDA 0.00
Effective Tax Rate (%) 0.00
Particulars MAR 2025 (Values in Cr)
Revenue 16.82
Operating Expense 9.33
Net Profit 6.21
Net Profit Margin (%) 36.92
Earnings Per Share (EPS) 1.02
EBITDA 8.52
Effective Tax Rate (%) 19.66
Particulars MAR 2026 (Values in Cr)
Revenue 71.58
Operating Expense 42.81
Net Profit 22.29
Net Profit Margin (%) 31.13
Earnings Per Share (EPS) 3.59
EBITDA 35.07
Effective Tax Rate (%) 23.84
Particulars MAR 2025 (Values in Cr)
Revenue 59.00
Operating Expense 34.54
Net Profit 18.63
Net Profit Margin (%) 31.57
Earnings Per Share (EPS) 3.06
EBITDA 28.10
Effective Tax Rate (%) 24.53
Particulars MAR 2024 (Values in Cr)
Revenue 52.22
Operating Expense 29.65
Net Profit 16.64
Net Profit Margin (%) 31.86
Earnings Per Share (EPS) 168.04
EBITDA 25.34
Effective Tax Rate (%) 27.14
Particulars MAR 2023 (Values in Cr)
Revenue 44.01
Operating Expense 26.08
Net Profit 13.26
Net Profit Margin (%) 30.12
Earnings Per Share (EPS) 133.93
EBITDA 19.66
Effective Tax Rate (%) 26.12
Particulars MAR 2025 (Values in Cr)
Book Value / Share 7.54
ROE % 52.20
ROCE % 48.32
Total Debt to Total Equity 0.52
EBITDA Margin 41.16
Particulars MAR 2024 (Values in Cr)
Book Value / Share 272.53
ROE % 41.51
ROCE % 44.10
Total Debt to Total Equity 0.58
EBITDA Margin 41.14
Particulars MAR 2023 (Values in Cr)
Book Value / Share 229.54
ROE % 84.45
ROCE % 74.77
Total Debt to Total Equity 0.55
EBITDA Margin 45.75
Particulars MAR 2022 (Values in Cr)
Book Value / Share 93.86
ROE % 95.05
ROCE % 80.98
Total Debt to Total Equity 0.64
EBITDA Margin 37.05
Particulars MAR 2025 (Values in Cr)
Book Value / Share 7.40
ROE % 51.57
ROCE % 47.49
Total Debt to Total Equity 0.53
EBITDA Margin 48.02
Particulars MAR 2024 (Values in Cr)
Book Value / Share 269.26
ROE % 40.13
ROCE % 43.93
Total Debt to Total Equity 0.55
EBITDA Margin 41.68
Particulars MAR 2023 (Values in Cr)
Book Value / Share 230.56
ROE % 58.08
ROCE % 55.58
Total Debt to Total Equity 0.43
EBITDA Margin 44.99
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 7.21
Total Assets 88.51
Total Liabilities 88.51
Total Equity 46.29
Share Outstanding 6
Price to Book Ratio 0.00
Return on Assets (%) 21.60
Return on Capital (%) 29.32
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 11.85
Total Assets 57.29
Total Liabilities 57.29
Total Equity 33.26
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 28.97
Return on Capital (%) 33.88
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 15.05
Total Assets 36.62
Total Liabilities 36.62
Total Equity 22.72
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 36.92
Return on Capital (%) 41.6
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 1.57
Total Assets 17.77
Total Liabilities 17.77
Total Equity 9.29
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 49.67
Return on Capital (%) 57.92
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 6.72
Total Assets 74.97
Total Liabilities 74.97
Total Equity 45.43
Share Outstanding 6
Price to Book Ratio 0.00
Return on Assets (%) 24.79
Return on Capital (%) 28.88
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 11.64
Total Assets 50.80
Total Liabilities 50.80
Total Equity 26.66
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 19.54
Return on Capital (%) 23.42
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 14.78
Total Assets 35.00
Total Liabilities 35.00
Total Equity 22.82
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 37.88
Return on Capital (%) 40.7
Particulars MAR 2025 (Values in Cr)
Net Income 25.60
Cash from Operations 13.40
Cash from Investing -15.17
Cash from Financing 1.81
Net change in Cash -4.64
Free Cash Flow 22.28
Particulars MAR 2024 (Values in Cr)
Net Income 16.92
Cash from Operations 5.26
Cash from Investing -5.40
Cash from Financing -1.24
Net change in Cash -3.20
Free Cash Flow 8.05
Particulars MAR 2023 (Values in Cr)
Net Income 18.22
Cash from Operations 28.60
Cash from Investing -15.62
Cash from Financing 5.25
Net change in Cash 13.48
Free Cash Flow 43.85
Particulars MAR 2022 (Values in Cr)
Net Income 11.99
Cash from Operations 1.70
Cash from Investing -1.36
Cash from Financing 2.79
Net change in Cash 0.42
Free Cash Flow 3.07
Particulars MAR 2025 (Values in Cr)
Net Income 24.88
Cash from Operations 13.04
Cash from Investing -15.17
Cash from Financing 1.81
Net change in Cash -4.91
Free Cash Flow 21.91
Particulars MAR 2024 (Values in Cr)
Net Income 22.83
Cash from Operations 2.36
Cash from Investing -2.75
Cash from Financing -0.99
Net change in Cash -3.14
Free Cash Flow 5.12
Particulars MAR 2023 (Values in Cr)
Net Income 17.94
Cash from Operations 28.64
Cash from Investing -14.47
Cash from Financing 3.50
Net change in Cash 13.04
Free Cash Flow 41.86
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
APOLLO HOSPITALS ENTERPRISE LT 8099.40 59.53 12.29 116456.95 6680.00 8490.30
FORTIS MALAR HOSPITALS LIMITED 53.36 24.14 2.91 100.01 40.75 77.00
SHREE PACETRONIX LTD. 130.75 15.60 2.75 49.03 66.10 283.15
TRANSGENE BIOTEK LTD. 3.10 0.00 2.80 23.49 1.83 5.26
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
APOLLO HOSPITALS ENTERPRISE LT 8099.40 77.57 11.68 116456.95 6680.00 8490.30
[-] 0.0 0.0 0.0 0.0 0.0 0.0
CHENNAI MEENAKSHI MULTISPECIAL 39.30 0.00 -9.56 29.36 30.30 57.48
KOVAI MEDICAL CENTER & HOSPITA 5372.55 24.04 4.45 5877.57 5010.00 6725.00

Gaudium Ivf N Women H L shareholding pattern

Holding
19.39%
71.29%
6.69%
2.62%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

Gaudium Ivf N Women H L Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
112.39 -1.99 redarrow
red-green-graph indicator
9 Bearish
7 Bullish
  • 5 Days 116.10
  • 26 Days 112.00
  • 10 Days 115.40
  • 50 Days 101.70
  • 12 Days 115.10
  • 100 Days 98.40
  • 20 Days 113.60
  • 200 Days 98.40
114.68 PIVOT
First Support 114.68 First Resistance 114.68 Second Support 114.68 Second Resistance 114.68 Third Support 114.68 Third Resistance 114.68
RSI 53.36 ADX 9.29 MACD 3.15 Williams % R -33.82 Commodity Channel Index (CCI) 3.10
Date 2026-04-27 Week 860905.00 Same Day 493940.00 Month 796557.00
1 Year 1.51 3 Year 1.48
Over 1 Month
-0.83% down
Over 1 Year
0.00% down
Over 3 Months
38.63% down
Over 3 Years
0.00% down
Over 6 Months
42.88% down
Over 5 Years
0.00% down

Gaudium Ivf N Women H L Corporate Actions

Top Gainers

Top Losers

stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Gaudium IVF and Women Health Ltd?

Answer Field

Gaudium IVF and Women Health Ltd share price is for NSE ₹ 112.39 & for BSE ₹ 111.85 as on Jun 02 2026 02:14 PM.

What is the Market Cap of Gaudium IVF and Women Health Ltd Share?

Answer Field

The market cap of Gaudium IVF and Women Health Ltd for NSE ₹ 0.00 & for BSE ₹ 0.00 as on Jun 02 2026 02:14 PM.

What is the 52 Week High and Low of Gaudium IVF and Women Health Ltd?

Answer Field

The 52 Week High and Low of Gaudium IVF and Women Health Ltd for NSE is ₹ 133.00 and ₹ 69.18 and for BSE is ₹ 133.00 and ₹ 69.50.

What is 1 year return for Gaudium IVF and Women Health Ltd?

Answer Field

The 1 year returns on the stock has been 0.00%.

What is the P/E Ratio of Gaudium IVF and Women Health Ltd Share?

Answer Field

As on Jun 02 2026 02:14 PM the price-to-earnings (PE) ratio for Gaudium IVF and Women Health Ltd share is 37.29.

What is the PB ratio of Gaudium IVF and Women Health Ltd Share?

Answer Field

As on Jun 02 2026 02:14 PM, the price-to-book (PB) ratio for Gaudium IVF and Women Health Ltd share is 20.50.

How to Buy Gaudium IVF and Women Health Ltd Share?

Answer Field

You can trade in Gaudium IVF and Women Health Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Gaudium IVF and Women Health Ltd Share on Bajaj Broking App?

Answer Field

To buy Gaudium IVF and Women Health Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Gaudium IVF and Women Health Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|